Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 136

1.

Accurate risk assessment of patients with asymptomatic hematuria for the presence of bladder cancer.

Cha EK, Tirsar LA, Schwentner C, Hennenlotter J, Christos PJ, Stenzl A, Mian C, Martini T, Pycha A, Shariat SF, Schmitz-Dräger BJ.

World J Urol. 2012 Dec;30(6):847-52. doi: 10.1007/s00345-012-0979-x. Epub 2012 Nov 5.

2.

Immunocytology is a strong predictor of bladder cancer presence in patients with painless hematuria: a multicentre study.

Cha EK, Tirsar LA, Schwentner C, Christos PJ, Mian C, Hennenlotter J, Martini T, Stenzl A, Pycha A, Shariat SF, Schmitz-Dräger BJ.

Eur Urol. 2012 Jan;61(1):185-92. doi: 10.1016/j.eururo.2011.08.073. Epub 2011 Sep 9.

3.

Impact of clinical factors, including a point-of-care nuclear matrix protein-22 assay and cytology, on bladder cancer detection.

Lotan Y, Capitanio U, Shariat SF, Hutterer GC, Karakiewicz PI.

BJU Int. 2009 May;103(10):1368-74. doi: 10.1111/j.1464-410X.2009.08360.x. Epub 2009 Mar 11. Erratum in: BJU Int. 2010 Apr;105(7):1036.

4.

Prospective external validation of a bladder cancer detection model.

Lotan Y, Svatek RS, Krabbe LM, Xylinas E, Klatte T, Shariat SF.

J Urol. 2014 Nov;192(5):1343-8. doi: 10.1016/j.juro.2014.05.087. Epub 2014 May 21.

PMID:
24859442
5.

Evaluation of diagnostic strategies for bladder cancer using computed tomography (CT) urography, flexible cystoscopy and voided urine cytology: results for 778 patients from a hospital haematuria clinic.

Blick CG, Nazir SA, Mallett S, Turney BW, Onwu NN, Roberts IS, Crew JP, Cowan NC.

BJU Int. 2012 Jul;110(1):84-94. doi: 10.1111/j.1464-410X.2011.10664.x. Epub 2011 Nov 28.

6.

Stratifying risk of urinary tract malignant tumors in patients with asymptomatic microscopic hematuria.

Loo RK, Lieberman SF, Slezak JM, Landa HM, Mariani AJ, Nicolaisen G, Aspera AM, Jacobsen SJ.

Mayo Clin Proc. 2013 Feb;88(2):129-38. doi: 10.1016/j.mayocp.2012.10.004. Epub 2013 Jan 9.

PMID:
23312369
7.

Assessment of asymptomatic microscopic hematuria in adults.

Sharp VJ, Barnes KT, Erickson BA.

Am Fam Physician. 2013 Dec 1;88(11):747-54. Review.

8.

Can reproductive characteristics predict bladder cancer in women with haematuria?

Yavuzcan A, Caglar M, Kayikci MA, Basaran E, Tekin A, Ozdemir E, Dilbaz S, Ustun Y, Cam HK.

Asian Pac J Cancer Prev. 2013;14(9):5107-10.

9.

The use of molecular analyses in voided urine for the assessment of patients with hematuria.

Beukers W, Kandimalla R, van Houwelingen D, Kovacic H, Chin JF, Lingsma HF, Dyrskjot L, Zwarthoff EC.

PLoS One. 2013 Oct 15;8(10):e77657. doi: 10.1371/journal.pone.0077657. eCollection 2013.

10.

Utility of urine cytology in the workup of asymptomatic microscopic hematuria in low-risk patients.

Feifer AH, Steinberg J, Tanguay S, Aprikian AG, Brimo F, Kassouf W.

Urology. 2010 Jun;75(6):1278-82. doi: 10.1016/j.urology.2009.09.091. Epub 2010 Feb 7.

PMID:
20138655
11.

A pretreatment nomogram predicting recurrence- and progression-free survival for nonmuscle invasive bladder cancer in Japanese patients.

Yamada T, Tsuchiya K, Kato S, Kamei S, Taniguchi M, Takeuchi T, Yamamoto N, Ehara H, Deguchi T.

Int J Clin Oncol. 2010 Jun;15(3):271-9. doi: 10.1007/s10147-010-0049-6. Epub 2010 Mar 2.

PMID:
20195678
12.

Gender disparities in hematuria evaluation and bladder cancer diagnosis: a population based analysis.

Garg T, Pinheiro LC, Atoria CL, Donat SM, Weissman JS, Herr HW, Elkin EB.

J Urol. 2014 Oct;192(4):1072-7. doi: 10.1016/j.juro.2014.04.101. Epub 2014 May 14.

13.

Use of a multitarget fluorescence in situ hybridization assay to diagnose bladder cancer in patients with hematuria.

Sarosdy MF, Kahn PR, Ziffer MD, Love WR, Barkin J, Abara EO, Jansz K, Bridge JA, Johansson SL, Persons DL, Gibson JS.

J Urol. 2006 Jul;176(1):44-7.

PMID:
16753364
14.

Nomogram for predicting disease recurrence after radical cystectomy for transitional cell carcinoma of the bladder.

Karakiewicz PI, Shariat SF, Palapattu GS, Gilad AE, Lotan Y, Rogers CG, Vazina A, Gupta A, Bastian PJ, Perrotte P, Sagalowsky AI, Schoenberg M, Lerner SP.

J Urol. 2006 Oct;176(4 Pt 1):1354-61; discussion 1361-2.

PMID:
16952631
15.

Evaluation of an Epigenetic Profile for the Detection of Bladder Cancer in Patients with Hematuria.

van Kessel KE, Van Neste L, Lurkin I, Zwarthoff EC, Van Criekinge W.

J Urol. 2016 Mar;195(3):601-7. doi: 10.1016/j.juro.2015.08.085. Epub 2015 Aug 29.

PMID:
26327355
16.

Bladder cancer: diagnosis with diffusion-weighted MR imaging in patients with gross hematuria.

Abou-El-Ghar ME, El-Assmy A, Refaie HF, El-Diasty T.

Radiology. 2009 May;251(2):415-21. doi: 10.1148/radiol.2503080723. Epub 2009 Mar 20.

PMID:
19304915
17.

Diagnostic value of a urine-based tumor marker for screening lower urinary tract in low-risk patients with asymptomatic microscopic hematuria.

Sagnak L, Ersoy H, Gucuk O, Ozok U, Topaloglu H.

Urol Int. 2011;87(1):35-41. doi: 10.1159/000325376. Epub 2011 Jun 3.

PMID:
21654152
18.

Microscopic hematuria as a predictive factor for detecting bladder cancer at cystoscopy in women with irritative voiding symptoms.

Wu JM, Williams KS, Hundley AF, Jannelli ML, Visco AG.

Am J Obstet Gynecol. 2006 May;194(5):1423-6. Epub 2006 Mar 30.

PMID:
16579943
19.

Impact of risk factors on the performance of the nuclear matrix protein 22 point-of-care test for bladder cancer detection.

Lotan Y, Shariat SF; NMP22 Study Group.

BJU Int. 2008 Jun;101(11):1362-7. doi: 10.1111/j.1464-410X.2008.07473.x. Epub 2008 Feb 18.

20.

Characteristics and significant predictors of detecting underlying diseases in adults with asymptomatic microscopic hematuria: a large case series of a Korean population.

Kang M, Lee S, Jeong SJ, Hong SK, Byun SS, Lee SE, Jeong CW.

Int J Urol. 2015 Apr;22(4):389-93. doi: 10.1111/iju.12697. Epub 2015 Jan 12.

Items per page

Supplemental Content

Write to the Help Desk